search.noResults

search.searching

note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
1256 infection control & hospital epidemiology october 2017, vol. 38, no. 10 table 2. Continued Control Characteristic


Discharge disposition Home SNF


Other Case (N =52) (N=156)


154 32 22


32 13 7


20.8 40.6 31.8


Univariable Analysis OR (95% CI)


Reference


2.61 (1.17–5.84) 1.78 (0.67–4.73)


Multivariable Analysisb P Value OR (95% CI) ...


.020 .248


Reference


2.24 (0.88–5.69) 1.08 (0.31–3.75)


P Value ...


.092 .904


NOTE. SD, standard deviation; IQR, interquartile ratio; OR, odds ratio; CI, confidence interval; BMI, body mass index, CCI, Charlson comor- bidity index, ASA, American Society of Anesthesiologists; CKD, chronic kidney disease; PPI, proton pump inhibitor; SNF, skilled nursing


facility. aData reported as mean (SD), median (IQR) or OR (95% CI). bMultivariable analysis controls for BMI, ASA classification, and previous antibiotic use in the past 6 months. cASA classification: 1, a normal healthy patient; 2, a patient with mild systemic disease; 3, a patient with severe systemic disease; 4, a patient with severe systemic disease that is a constant threat to life; 5, a moribund patient who is not expected to survive without the operation.


Risk Factor Analysis


From univariable analysis, the following variables were asso- ciated with statistically significant increased odds of CDI: number of admissions in past year (OR, 2.25; P<.001), ASA classification of 4–5 versus 1–2 (OR, 10.45; P<.001), anti- biotic use in the previous 6 months (OR, 2.80; P=.002), proton pump inhibitor or H2 receptor blocker use in the previous 6 months (OR, 2.14; P=.026), antibiotics continued more than 24 hours postoperatively (OR, 5.44; P<.001), and nonperioperative antibiotics (OR, 3.59; P<.001) (Table 2). Controlling for BMI, ASA classification, and antibiotic use


in the previous 6 months, the following variables were asso- ciated with statistically significant increased odds of CDI by multivariable analysis: number of admissions in past year (OR, 2.33; P=.001), ASA class of 4–5 versus 1–2 (OR, 15.39; P<.001), antibiotic use in the previous 6 months (OR, 3.74; P<.001), antibiotics continued more than 24 hours post- operatively (OR, 3.38; P=.026), and nonperioperative anti- biotics (OR, 2.20; P=.038).


Outcomes


Length of stay during the postoperative admission was significantly increased on univariable analysis (OR, 1.16; P<.001) as well as multivariable analysis (OR, 1.14; P<.001) (Table 2). Length of stay was evaluated as a continuous variable, and for every additional admission in the previous year, odds of CDI increased by 14%. Discharge to skilled nursing facility versus home was also more likely for patients with CDI on univariable analysis (OR, 2.61; P=.020).


discussion


Our study examined incidence of and risk factors for CDI across multiple surgical specialties in one tertiary-care center. We found rates 4–5 times higher in the trauma and general


surgery units than in the orthopedic and neurosurgery units. This variability may be attributable to differences in patient factors such as overall health, antibiotic use, or healthcare setting exposure as well as surgical factors (eg, intra-abdominal trauma surgeries versus orthopedic joint surgeries). We found that having an ASA class of 4 or 5 increases the


odds of CDI 15-fold compared to an ASA class of 1 or 2. This suggests that the complexity of a patient’s illness may increase the risk of CDI. Interestingly, the complexity of the surgery itself, as represented by operative time and blood loss, does not correlate with increased odds of CDI. If the perioperative antibiotic is continued more than


24 hours after surgery, outside of the perioperative window, the odds of CDI increase 3.34-fold. This finding has been reported previously and highlights the importance of mini- mizing antibiotic use to only the perioperative period if possible.8 Use of antibiotics while in the hospital other than the perioperative antibiotic was also associated with 2.2 times greater odds of CDI. Antibiotic exposure as long as 6 months prior to surgery increases the odds of CDI more than 3-fold. Although the surgeon cannot change the fact that their patient received antibiotics, it should alert him or her to the fact that the patient may be at higher risk for postoperative CDI. Previous studies have shown a correlation between CDI and


hospital admission in the previous 3 months.9 Our study reports that this association extends to 12 months. We found that the number of hospital admissions in the past year increases the odds of CDI by 133% for each admission. Given the extensive environmental contamination with C. difficile in healthcare settings, this is a biologically plausible finding. This study has several limitations. First, the hospital data-


base only tracks patients within the hospital system. Therefore, CDI diagnoses, admissions, and medications from other facilities were not tracked. This study has a relatively small sample size of 52 cases, which limits the power of our statistical analysis. Further, this case-control study is subject to the limitations of all case-control studies.10


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136  |  Page 137  |  Page 138  |  Page 139  |  Page 140  |  Page 141  |  Page 142  |  Page 143  |  Page 144